Status:
COMPLETED
A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to collect information on how Ryzodeg® works in real world patients and to see if Ryzodeg® can lower blood sugar levels. Participants will get Ryzodeg® as prescribed to the...
Eligibility Criteria
Inclusion
- Informed consent obtained before any study-related activities. Study-related activities are any procedures related to recording of data according to the protocol.
- The decision to initiate or switch into treatment with commercially available Ryzodeg® has been made by the patient/Legally Acceptable Representative (LAR) and the treating physician based on local label before, and independently from, the decision to include the patient in this study.
- Male or female, age above or equal to 18 years at the time of signing informed consent.
- Diagnosed with T2DM and treated with any anti-hyperglycaemic medication(s) other than Ryzodeg® for at least 26 weeks prior to signing informed consent.
- Available and documented HbA1c value for 12 weeks or less prior to signing informed consent.
Exclusion
- Hypersensitivity to the active substance or to any of the excipients as specified in the Ryzodeg® local label.
- Previous participation in this study. Participation is defined as signed informed consent.
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.
- Previous treatment with Ryzodeg®.
Key Trial Info
Start Date :
July 29 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 11 2020
Estimated Enrollment :
1122 Patients enrolled
Trial Details
Trial ID
NCT04042441
Start Date
July 29 2019
End Date
December 11 2020
Last Update
September 19 2024
Active Locations (64)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal North Shore Hospital
St Leonards, New South Wales, Australia, 2065
2
Illawarra Diabetes Service Clinical Trials & Research Unit
Wollongong, New South Wales, Australia, 2500
3
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia, 4029
4
Mater Hospital Brisbane
South Brisbane, Queensland, Australia, 4101